Lilly posts galunisertib PFS results in prostate cancer; registers new bimagrumab HFpEF trialNov 6Weekly roundup, 7 itemsbimagrumabEli LillyUpdated
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
GSK discloses FDA hold on infant pneumococcal vaccine study; posts two Phase 3/4 resultsOct 9Weekly roundup, 9 itemsdostarlimab-gxlyGlaxoSmithKlineUpdated
Sign inSign in